AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitaliptin M 50mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Leeford Healthcare Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaliptin M 50mg/500mg Tablet SR

Duo-Med 50mg/500mg Extended-Release Tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications, such as renal impairment and vision loss, and may lessen the risk of cardiovascular events. Duo-Med 50mg/500mg Extended-Release Tablets can be used as monotherapy or in conjunction with other diabetes treatments. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal distress. Consistent daily dosing, at the same time each day, maximizes benefits; discontinuation should only occur under medical supervision. Adherence to your prescribed diet and exercise regimen is crucial for diabetes control; lifestyle significantly impacts management. Common side effects include nausea, diarrhea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for all patients. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Potential drug interactions exist; disclose all medications to ensure safe use. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Sitaliptin M 50mg/500mg Tablet SR

No text was provided to rewrite.

Uses of Sitaliptin M 50mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Sitaliptin M 50mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sitaliptin M 50mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this medicine with food.

Common Side effects of Sitaliptin M 50mg/500mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaliptin M 50mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitaliptin M 50mg/500mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer this medication with a meal.

How Sitaliptin M 50mg/500mg Tablet SR works:

Sitaliptin M 50mg/500mg extended-release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaliptin M 50mg/500mg SR tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaliptin M 50mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sitaliptin M 50mg/500mg tablet is likely unsafe for breastfeeding mothers. Preliminary human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaliptin M 50mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Sitaliptin M 50mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The extended-release Sitaliptin M 50mg/500mg tablet is likely contraindicated for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take Sitaliptin M 50mg/500mg Tablet SR :

Should you forget a Sitaliptin M 50mg/500mg Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaliptin M 50mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Treatment

FAQs on Sitaliptin M 50mg/500mg Tablet SR

Sitaliptin M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitaliptin M 50mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and impaired balance. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaliptin M 50mg/500mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitaliptin M 50mg/500mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaliptin M 50mg/500mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitagliptin/Metformin 50mg/500mg SR tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaliptin M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaliptin M 50mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitaliptin M 50mg/500mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaliptin M 50mg/500mg SR tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg SR tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sitaliptin M 50mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitaliptin M 50mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when coupled with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitaliptin M 50mg/500mg SR Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaliptin M 50mg/500mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaliptin M 50mg/500mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg SR tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged use of Sitaliptin M 50mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaliptin M 50mg/500mg T...
241
MRP 280
13% off